(Q46863513)

25 December 2017

title

Pharmacokinetics and tissue distribution of pterostilbene in the rat. (English)

1 reference

25 December 2017

1 reference

6

1 reference

25 December 2017

Michele Azzolini

object named as

Michele Azzolini

1

0 references

Andrea Mattarei

object named as

Andrea Mattarei

3

0 references

author name string

Martina La Spina

2

1 reference

25 December 2017

Cristina Paradisi

4

1 reference

25 December 2017

Mario Zoratti

5

1 reference

25 December 2017

publication date

22 August 2014

1 reference

25 December 2017

Molecular Nutrition and Food Research

published in

1 reference

25 December 2017

volume

58

1 reference

25 December 2017

issue

11

1 reference

25 December 2017

page(s)

2122-2132

1 reference

25 December 2017

A review of pterostilbene antioxidant activity and disease modification

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Pterostilbene: Biomedical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Dietary intake of pterostilbene, a constituent of blueberries, inhibits the beta-catenin/p65 downstream signaling pathway and colon carcinogenesis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Resveratrol, pterostilbene, and piceatannol in vaccinium berries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

A stress-inducible resveratrol O-methyltransferase involved in the biosynthesis of pterostilbene in grapevine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Occurrence of resveratrol and pterostilbene in age-old darakchasava, an ayurvedic medicine from India

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Anti-inflammatory action of pterostilbene is mediated through the p38 mitogen-activated protein kinase pathway in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Pterostilbene ameliorates tumor necrosis factor alpha-induced pancreatitis in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Pterostilbene, a natural analogue of resveratrol, potently inhibits 7,12-dimethylbenz[a]anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA)-induced mouse skin carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Pterostilbene is more potent than resveratrol in preventing azoxymethane (AOM)-induced colon tumorigenesis via activation of the NF-E2-related factor 2 (Nrf2)-mediated antioxidant signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Pterostilbene, an active constituent of blueberries, suppresses aberrant crypt foci formation in the azoxymethane-induced colon carcinogenesis model in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Pterostilbene acts through metastasis-associated protein 1 to inhibit tumor growth, progression and metastasis in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Pterostilbene, a bioactive component of blueberries, suppresses the generation of breast cancer stem cells within tumor microenvironment and metastasis via modulating NF-κB/microRNA 448 circuit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Pterostilbene and cancer: current review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Pterostilbene-induced tumor cytotoxicity: a lysosomal membrane permeabilization-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Pterostilbene, a new agonist for the peroxisome proliferator-activated receptor alpha-isoform, lowers plasma lipoproteins and cholesterol in hypercholesterolemic hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Antihyperglycemic activity of phenolics from Pterocarpus marsupium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Effect of pterostilbene on hepatic key enzymes of glucose metabolism in streptozotocin- and nicotinamide-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Cellular and behavioral effects of stilbene resveratrol analogues: implications for reducing the deleterious effects of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

A berry thought-provoking idea: the potential role of plant polyphenols in the treatment of age-related cognitive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Reporter protein complementation imaging assay to screen and study Nrf2 activators in cells and living animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Nrf2-Keap1 signaling as a potential target for chemoprevention of inflammation-associated carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

The Keap1-Nrf2 cell defense pathway--a promising therapeutic target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Pterostilbene inhibits colorectal aberrant crypt foci (ACF) and colon carcinogenesis via suppression of multiple signal transduction pathways in azoxymethane-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Inhibition of human recombinant cytochromes P450 CYP1A1 and CYP1B1 by trans-resveratrol methyl ethers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Methylation of dietary flavones greatly improves their hepatic metabolic stability and intestinal absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Determination of pterostilbene in rat plasma by a simple HPLC-UV method and its application in pre-clinical pharmacokinetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Pharmacokinetics of pterostilbene in Sprague-Dawley rats: the impacts of aqueous solubility, fasting, dose escalation, and dosing route on bioavailability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Pharmacometrics of pterostilbene: preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Cranberry and blueberry: evidence for protective effects against cancer and vascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Analysis of safety from a human clinical trial with pterostilbene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Dietary administration of high doses of pterostilbene and quercetin to mice is not toxic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Analytical method development for synthesized conjugated metabolites of trans-resveratrol, and application to pharmacokinetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Determination of quercetin and resveratrol in whole blood--implications for bioavailability studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Quantification of trans-resveratrol and its metabolites in rat plasma and tissues by HPLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Structural identification of mouse urinary metabolites of pterostilbene using liquid chromatography/tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Differences in the glucuronidation of resveratrol and pterostilbene: altered enzyme specificity and potential gender differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Bioaccumulation of resveratrol metabolites in myocardial tissue is dose-time dependent and related to cardiac hemodynamics in diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Resveratrol metabolism in a non-human primate, the grey mouse lemur (Microcebus murinus), using ultra-high-performance liquid chromatography-quadrupole time of flight

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Enhancement of intestinal absorption of akebia saponin D by borneol and probenecid in situ and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Pleiotropic mechanisms facilitated by resveratrol and its metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Conjugated quercetin glucuronides as bioactive metabolites and precursors of aglycone in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Distribution of [3H]trans-resveratrol in rat tissues following oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Sulfate metabolites provide an intracellular pool for resveratrol generation and induce autophagy with senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Inhibition of cancer growth by resveratrol is related to its low bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Pharmacokinetics, tissue distribution and excretion study of resveratrol and its prodrug 3,5,4'-tri-O-acetylresveratrol in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201400244

Tissue distribution of quercetin in rats and pigs.

21 January 2018

1 reference

23 June 2024

https://opencitations.net/index/api/v1/citations/10.1093/JN/135.7.1718

Identifiers

DOI

10.1002/MNFR.201400244

1 reference

25 December 2017

1 reference

25 December 2017